Wellcome Trust
http://www.wellcome.ac.uk/News/2015/index.htm
.
Wellcome Trust-funded vaccines company acquired by GSK
GlycoVaxyn, a Swiss-based biopharmaceutical company, which has received funding from the Wellcome Trust Innovations division, has been acquired by global pharma firm GlaxoSmithKline (GSK) for $190 million (approximately £124 million).
20 February 2015